000			01647nam a22004335a 4500
005			20250914164906.0
006			m d
007			cr nn 008maaau
008			090204s2007 gw j eng d
020			_a9783540495291 (electronic bk.)
020			_a9783540278672 (paper)
035			_a(Springer)978-3-540-27867-2
039		9	_a200902041853 _bmuhaimin _y04-04-2008 _zmuhaimin
082	0	0	_a615.19 _222
090			_aebook
245	0	0	_aAppropriate Dose Selection _bHow to Optimize Clinical Drug Development _h[electronic resource] / _cedited by J. Venitz, W. Sittner.
260			_aBerlin, Heidelberg : _bSpringer-Verlag Berlin Heidelberg, _c2007.
300			_axvi, 216 p. : _bill. (some col.), digital ; _c22 cm.
440		0	_aErnst Schering Research Foundation Workshop, _x0947-6075 ; _v59
650		0	_aDrugs _xDose-response relationship.
650		0	_aCancer _xDrug testing.
650		0	_aDrug development.
650	1	4	_aBiomedicine.
650	2	4	_aPharmacology/Toxicology.
650	2	4	_aMedicine/Public Health, general.
650	2	4	_aBiochemistry, general.
700	1		_aVenitz, J.
700	1		_aSittner, W.
710	2		_aSpringerLink (Online service)
773	0		_tSpringer e-books
856	4	0	_uhttp://dx.doi.org/10.1007/978-3-540-49529-1
856	4		_uhttps://link-springer-com.eresourcesptsl.ukm.remotexs.co/book/10.1007/978-3-540-49529-1
907			_a.b14152940 _b2024-01-29 _c2019-11-12
942			_n0 _kebook
914			_avtls003372895
998			_ah _b2008-04-04 _cm _dz _feng _ggw _y0 _z.b14152940
999			_c411274 _d411274